In bladder cancer (BLCA), the increase in the expression level of METL3 can upregulate m6A levels of the CDCP1 gene, which promotes the proliferation, migration, and invasion of BLCA [37, 38]. This evidence concerns the gene CDCP1 and urinary bladder cancer.